Selecta Biosciences Inc (NASDAQ:SELB)
| 1.05 Delayed Data As of May 26 |  0.00 / 0.00%Today’s Change | 0.67 Today|||52-Week Range 2.73 | -7.08% Year-to-Date |
Latest SELB News | Press Releases
No recent news for Selecta Biosciences Inc.
Today’s Trading
| Previous close | 1.05 |
| Today’s open | 1.05 |
| Day’s range | 1.03 - 1.07 |
| Volume | 33,698 |
| Average volume (3 months) | 1,206,365 |
| Market cap | $161.1M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -255.11% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +30.21% |
| P/E ratio | NM |
| Price/Sales | 1.49 |
| Price/Book | 1.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LRMRLarimar Therapeutics... | -0.03 | -0.79% |
| VXRTVaxart Inc | -0.01 | -1.24% |
| XBITXBiotech Inc | +0.11 | +1.95% |
| CUECue Biopharma Inc | -0.05 | -1.27% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $110.8M |
| Annual profit (last year) | $35.4M |
| Net profit margin | 31.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
